Genjie Wang

Shangqiu, 476000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Corrigendum to "Factors influencing the efficacy of nebulized colistimethate sodium in the treatment of severe lung infection caused by carbapenem-resistant gram-negative bacteria" [International Journal of Infectious Diseases. 2026 Jun; 167:108588].

Corrigendum to "Factors influencing the efficacy of nebulized colistimethate sodium in the treatment of severe lung infection caused by carbapenem-resistant gram-negative bacteria" [International Journal of Infectious Diseases. 2026 Jun; 167:108588].

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: May 30, 2026

Comparative Effectiveness of Pomalidomide-Based Regimens in Relapsed/Refractory Multiple Myeloma: A Multicenter Real-World Analysis in China.

Comparative Effectiveness of Pomalidomide-Based Regimens in Relapsed/Refractory Multiple Myeloma: A Multicenter Real-World Analysis in China.

Journal: Cancers

Published: February 25, 2026

Factors influencing the efficacy of nebulized colistimethate sodium in the treatment of severe lung infection caused by carbapenem-resistant gram-negative bacteria.

Factors influencing the efficacy of nebulized colistimethate sodium in the treatment of severe lung infection caused by carbapenem-resistant gram-negative bacteria.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: February 09, 2026

Comparison of the efficacy of thalidomide combined with low-dose rituximab and low-dose rituximab alone in the treatment of steroid-resistant/refractory adult patients with primary immune thrombocytopenia: an open-label trial.

Comparison of the efficacy of thalidomide combined with low-dose rituximab and low-dose rituximab alone in the treatment of steroid-resistant/refractory adult patients with primary immune thrombocytopenia: an open-label trial.

Journal: Frontiers in medicine

Published: August 13, 2025

A retrospective study on effectiveness of combined recombinant human interferon-α-1b, interleukin-2, and thalidomide for the treatment of acute myeloid leukemia in various disease states.

A retrospective study on effectiveness of combined recombinant human interferon-α-1b, interleukin-2, and thalidomide for the treatment of acute myeloid leukemia in various disease states.

Journal: Annals of translational medicine

Published: October 20, 2022

HMGA2 regulates acute myeloid leukemia progression and sensitivity to daunorubicin via Wnt/β-catenin signaling.

HMGA2 regulates acute myeloid leukemia progression and sensitivity to daunorubicin via Wnt/β-catenin signaling.

Journal: International journal of molecular medicine

Published: December 18, 2018

c-Myc, RMRP, and miR-34a-5p form a positive-feedback loop to regulate cell proliferation and apoptosis in multiple myeloma.

c-Myc, RMRP, and miR-34a-5p form a positive-feedback loop to regulate cell proliferation and apoptosis in multiple myeloma.

Journal: International journal of biological macromolecules

Published: September 07, 2018

PML/RARa blocks the differentiation and promotes the proliferation of acute promyelocytic leukemia through activating MYB expression by transcriptional and epigenetic regulation mechanisms.

PML/RARa blocks the differentiation and promotes the proliferation of acute promyelocytic leukemia through activating MYB expression by transcriptional and epigenetic regulation mechanisms.

Journal: Journal of cellular biochemistry

Published: January 06, 2018

AML1/ETO trans-activates c-KIT expression through the long range interaction between promoter and intronic enhancer.

AML1/ETO trans-activates c-KIT expression through the long range interaction between promoter and intronic enhancer.

Journal: Journal of cellular biochemistry

Published: September 16, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026